Candriam Equities L Biotechnology C - Thesaurierung/ LU0108459040 /
| NAV22.01.2025 | Diff.+1,9400 | Ertragstyp | Ausrichtung | Fondsgesellschaft |
|---|---|---|---|---|
| 855,9900USD | +0,23% | thesaurierend | Aktien weltweit | Candriam ▶ |
Monatliche Performance
| Jan | Feb | Mrz | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez | Gesamt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2000 | - | - | - | - | 9,07 | 39,65 | -8,01 | 23,69 | 10,72 | -11,24 | -13,74 | 4,18 | - |
| 2001 | -2,63 | -12,28 | -20,64 | 18,86 | 9,28 | 4,98 | -14,90 | 2,77 | -19,22 | 16,98 | 9,78 | 0,03 | -16,11% |
| 2002 | -15,77 | -3,67 | 2,35 | -17,67 | 0,37 | -18,94 | 1,98 | 0,98 | -9,51 | 9,49 | 7,68 | -10,47 | -45,29% |
| 2003 | -0,87 | -4,59 | 6,07 | 7,14 | 19,99 | -3,00 | 7,99 | -2,86 | 2,19 | 2,19 | -1,66 | 6,66 | +43,75% |
| 2004 | 7,07 | 1,56 | -1,42 | -0,38 | -2,52 | -0,01 | -9,08 | 2,22 | 5,80 | -2,11 | 0,82 | 6,15 | +7,21% |
| 2005 | -3,81 | -5,19 | -3,97 | 3,02 | 6,36 | 2,85 | 10,12 | 1,25 | 2,79 | -3,40 | 5,66 | 1,29 | +16,93% |
| 2006 | 6,13 | 3,96 | -3,54 | -4,77 | -4,44 | 0,11 | -2,51 | 2,57 | 0,18 | 13,74 | 0,76 | -2,27 | +8,79% |
| 2007 | 2,29 | -3,54 | 2,03 | 7,46 | 0,08 | -5,87 | -2,83 | 1,88 | 5,51 | 2,14 | -2,82 | -5,95 | -0,63% |
| 2008 | -5,04 | -3,45 | 1,53 | 1,41 | 1,64 | -2,69 | 17,01 | -4,26 | -6,57 | -15,64 | -10,17 | 8,05 | -19,99% |
| 2009 | -1,37 | -7,11 | 6,21 | -0,50 | 2,87 | 7,09 | 29,17 | 2,60 | 1,37 | -11,25 | 7,99 | 5,19 | +44,45% |
| 2010 | 3,27 | 6,33 | 14,95 | -2,01 | -12,51 | -5,72 | 3,61 | -0,48 | 10,71 | 2,67 | -2,59 | 6,17 | +23,66% |
| 2011 | -0,63 | 0,72 | 5,91 | 4,53 | 2,94 | -1,78 | -3,57 | -8,01 | -6,69 | 7,93 | 0,69 | 1,78 | +2,57% |
| 2012 | 11,82 | 0,38 | 5,76 | 0,55 | -2,15 | 5,51 | 2,34 | 1,91 | 5,14 | -5,96 | 4,39 | -1,04 | +31,27% |
| 2013 | 9,67 | 1,01 | 8,08 | 6,09 | 3,28 | -2,75 | 14,25 | -2,44 | 9,94 | -2,80 | 6,53 | 1,61 | +64,48% |
| 2014 | 8,25 | 7,34 | -9,94 | -5,09 | 2,76 | 10,11 | -3,25 | 11,06 | -1,11 | 9,59 | 2,98 | 0,58 | +35,53% |
| 2015 | 4,47 | 4,53 | 1,86 | -5,10 | 10,73 | 0,63 | 4,16 | -10,95 | -11,39 | 7,80 | 3,42 | 0,32 | +8,14% |
| 2016 | -23,24 | -4,59 | 3,68 | 3,69 | 5,59 | -8,41 | 12,56 | -2,39 | 3,97 | -12,73 | 9,11 | -2,84 | -19,53% |
| 2017 | 5,50 | 6,84 | 0,08 | 1,07 | -2,95 | 9,37 | 2,39 | 6,82 | 0,89 | -6,61 | 0,13 | 1,45 | +26,68% |
| 2018 | 6,69 | -4,62 | -2,14 | -3,21 | 4,60 | 0,80 | 4,40 | 4,12 | -2,09 | -14,02 | 4,12 | -8,32 | -11,23% |
| 2019 | 13,12 | 3,56 | -0,57 | -4,95 | -4,48 | 9,42 | -2,21 | -2,37 | -4,52 | 11,18 | 11,96 | 2,77 | +34,96% |
| 2020 | -5,28 | -1,53 | -4,99 | 12,35 | 9,48 | 1,27 | -3,02 | 0,83 | 0,71 | -2,66 | 9,44 | 2,97 | +19,24% |
| 2021 | 1,80 | -2,60 | -4,29 | 2,71 | -2,27 | 6,34 | -1,47 | 3,88 | -4,25 | 0,15 | -4,39 | 2,40 | -2,66% |
| 2022 | -10,59 | -1,56 | 6,03 | -7,24 | -3,98 | 3,50 | 4,70 | 1,52 | -1,91 | 6,49 | 6,17 | -2,87 | -1,49% |
| 2023 | 2,90 | -5,67 | 0,23 | 2,26 | -0,95 | 1,42 | -0,59 | -0,24 | -4,49 | -6,13 | 6,15 | 13,62 | +7,16% |
| 2024 | 1,48 | 1,34 | -0,04 | -6,26 | 3,81 | 5,64 | 6,33 | 1,73 | -2,42 | -1,53 | 0,44 | -7,03 | - |
| 2025 | 0,89 | - | - | - | - | - | - | - | - | - | - | - | - |
Kennzahlen
| lfd. Jahr | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | |
|---|---|---|---|---|---|
| Volatilität | 19,28% | 18,79% | 17,56% | 20,26% | 22,81% |
| Sharpe Ratio | 0,68 | -0,91 | -0,06 | 0,24 | 0,10 |
| Bester Monat | +0,89% | +6,33% | +6,33% | +13,62% | +13,62% |
| Schlechtester Monat | -7,03% | -7,03% | -7,03% | -10,59% | -10,59% |
| Maximaler Verlust | -4,16% | -14,31% | -14,31% | -20,60% | -30,62% |
| Outperformance | -4,39% | - | -5,62% | +0,32% | -4,76% |
Alle Kurse in USD
Tranchen
| Titel | Ertragstyp | Rückn. Preis | 1 Jahr | 3 Jahre | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | thesaurierend | 2.073,4700 | +0,30% | +15,54% | |
| Candriam Equities L Biotech.I EU... | thesaurierend | 2.346,7500 | +6,72% | +35,12% | |
| Candriam Equities L Biotech.I GB... | thesaurierend | 3.570,7800 | +5,46% | +35,89% | |
| Candriam Equities L Biotech.V2 U... | thesaurierend | 1.889,6700 | +2,78% | +28,71% | |
| Candriam Equities L Biotech.C EU... | thesaurierend | 232,5600 | +6,13% | +34,99% | |
| Candriam Equities L Biotech.R GB... | thesaurierend | 376,8300 | +5,85% | +39,64% | |
| Candriam Equities L Biotech.R EU... | thesaurierend | 345,2500 | +7,11% | +38,66% | |
| Candriam Equities L Biotech.R-H ... | thesaurierend | 199,6900 | -1,87% | +12,51% | |
| Candriam Equities L Biotechnolog... | thesaurierend | 149,7300 | -1,32% | - | |
| Candriam Equities L Biotech.I US... | thesaurierend | 5.736,9600 | +2,18% | +24,48% | |
| Candriam Equities L Biotechnolog... | thesaurierend | 2.098,2500 | +2,28% | +25,02% | |
| Candriam Equities L Biotech.N US... | thesaurierend | 608,3000 | +1,26% | +23,09% | |
| Candriam Equities L Biotech.C-H ... | thesaurierend | 198,2500 | -0,20% | +15,57% | |
| Candriam Equities L Biotech.R US... | thesaurierend | 273,5000 | +2,55% | +27,77% | |
| Candriam Equities L Biotech.R-H ... | thesaurierend | 207,9000 | +0,64% | +18,50% | |
| Candriam Equities L Biotechnolog... | thesaurierend | 855,9900 | +1,64% | +24,56% | |
| Candriam Equities L Biotechnolog... | ausschüttend | 781,6000 | +1,61% | +24,44% |
Performance
| lfd. Jahr | +0,89% | ||
|---|---|---|---|
| 6 Monate | -7,54% | ||
| 1 Jahr | +1,64% | ||
| 3 Jahre | +24,56% | ||
| 5 Jahre | +27,21% | ||
| seit Beginn | +755,99% | ||
| Jahr | |||
| 2023 | +7,16% | ||
| 2022 | -1,49% | ||
| 2021 | -2,66% | ||
| 2020 | +19,24% | ||
| 2019 | +34,96% | ||
| 2018 | -11,23% | ||
| 2017 | +26,68% | ||
| 2016 | -19,53% | ||